Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) Sees Large Drop in Short Interest

Cryo-Cell International, Inc. (NYSEAMERICAN:CCELGet Free Report) was the target of a large decline in short interest in the month of June. As of June 15th, there was short interest totalling 10,900 shares, a decline of 6.0% from the May 31st total of 11,600 shares. Based on an average daily volume of 11,200 shares, the days-to-cover ratio is presently 1.0 days. Approximately 0.3% of the company’s stock are sold short.

Cryo-Cell International Price Performance

Shares of CCEL opened at $7.07 on Wednesday. Cryo-Cell International has a 52-week low of $3.67 and a 52-week high of $9.50. The company has a market capitalization of $57.27 million, a P/E ratio of 17.30 and a beta of 0.47.

Cryo-Cell International (NYSEAMERICAN:CCELGet Free Report) last released its earnings results on Monday, April 15th. The company reported $0.07 EPS for the quarter. The firm had revenue of $7.85 million for the quarter. Cryo-Cell International had a negative return on equity of 64.31% and a negative net margin of 31.02%.

Institutional Investors Weigh In On Cryo-Cell International

An institutional investor recently bought a new position in Cryo-Cell International stock. Rowlandmiller & PARTNERS.ADV purchased a new stake in Cryo-Cell International, Inc. (NYSEAMERICAN:CCELFree Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 14,433 shares of the company’s stock, valued at approximately $108,000. Rowlandmiller & PARTNERS.ADV owned 0.17% of Cryo-Cell International at the end of the most recent quarter. 10.44% of the stock is currently owned by institutional investors.

Cryo-Cell International Company Profile

(Get Free Report)

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.

See Also

Receive News & Ratings for Cryo-Cell International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryo-Cell International and related companies with's FREE daily email newsletter.